Beam Therapeutics secures $135m funds to expand pipeline of precision genetic medicines

Beam Therapeutics secures $135m funds to expand pipeline of precision genetic medicines

Source: 
Pharmaceutical Business Review
snippet: 

Proceeds from the financing will be used to advance the company’s development of next-generation CRISPR technologies, expand its pipeline of base editing programs, and further extend its scientific